SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-001890
Filing Date
2021-05-26
Accepted
2021-05-26 07:54:41
Documents
5
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 6-K zk2126102.htm 6-K 14996
2 REGISTRANT'S PRESS RELEASE DATED MAY 26, 2021. exhibit_1.htm EX-99 284943
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, exhibit_2.htm EX-99 299704
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2021 AND FOR THE THR exhibit_3.htm EX-99 155918
5 image00001.jpg GRAPHIC 5551
  Complete submission text file 0001178913-21-001890.txt   764458
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 21962749
SIC: 2834 Pharmaceutical Preparations